Swaraj Shares and Securities Private Limited ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement under Regulation ....

Listed-company acquisitionOpen offer triggeredStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹130.20

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+5.1% vs market

Pharmaceuticals peers, median of 147sector-0.1%+5.1% vs sector

On the reaction day the stock moved 5.1 pts more than Nifty Microcap 250 and 5.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0-0.1+5.1-0.1+5.1

Next day

+8.3+0.5+7.8-0.3+8.6

+12.1+1.1+11.0-0.0+12.2

+16.2+1.0+15.1+0.1+16.0

+13.4+1.4+12.0+0.0+13.4

+11.1+1.7+9.4+0.4+10.7

+6.8+2.1+4.7-0.3+7.1

15d

-7.4+3.9-11.3+1.4-8.8

-9.7+1.2-10.9-2.7-7.0

+6.3+6.7-0.4+1.4+4.9

-7.8+2.7-10.5-1.0-6.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

M/s Atibha Agriseeds Private Limited (Acquirer) has announced an Open Offer to acquire up to 3,90,000 equity shares (26.00% of voting capital) of Chemo Pharma Laboratories Limited from public shareholders at ₹110 per share, totaling a maximum consideration of ₹4.29 crore. The offer is triggered under SEBI (SAST) Regulations following a Share Purchase Agreement dated February 18, 2025, where the Acquirer agreed to buy 4,18,281 shares (27.89%) from selling promoters Citric India Limited and Mrs. Shanta Somani. This filing is a Pre-Offer Advertisement cum Corrigendum published on May 21, 2025, correcting the offer closing date to June 4, 2025. The tendering period runs from May 22, 2025, to June 4, 2025. The Independent Directors Committee has deemed the offer price fair and reasonable.

Likely market impact

Public shareholders of Chemo Pharma Laboratories can tender their shares at ₹110 between May 22 and June 4, 2025. The offer represents a mandatory open offer triggered by the Acquirer's purchase of a controlling stake from promoters, signaling a change in ownership of the listed company.